EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Da Hyun Kim, Ho Joon Im, Won Kyoung Jhang, Sung Han Kang

Frontiers in Pediatrics · 29.05.2026 · 14

DOI: 10.3389/fped.2026.1782412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 29.05.2026. Verfasst von Da Hyun Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Haploidentical peripheral blood hematopoietic stem cell transplantation (haploPBSCT) is increasingly performed for both malignant and nonmalignant diseases. This study evaluated the outcomes of critically ill patients after haploPBSCT who were admitted to the pediatric intensive care unit (PICU).

Methods

This single-center, retrospective study included pediatric patients who underwent haploPBSCT ( ex vivo αβ+ T-cell and CD19+ B-cell depleted after 2012) and were admitted to the PICU between 2010 and 2023. Data were collected from electronic medical records. The primary outcomes were 30-day mortality from the time of PICU admission and in-hospital mortality. Secondary analyses examined risk factors associated with these outcomes.

Results

A total of 63 patients met the inclusion criteria. The 30-day and in-hospital mortality rates were 33.3% and 50.8%, respectively. The most common reason for PICU admission was respiratory complications. In multivariate logistic regression analysis, chronic graft-vs.-host-disease was independently associated with 30-day mortality [ p = 0.043, odds ratio (OR) 4.515; 95% confidence interval (CI): 1.050–19.414], while ventilator use was an independent predictor of in-hospital mortality [ p = 0.046, OR 5.15 (95% CI: 1.029–25.724)]. Among patients who survived beyond 30 days in the PICU, 11 subsequently died, 10 of whom had received ventilator support for respiratory failure; pneumonia was the most common cause of death.

Conclusion

Thirty-day and in-hospital mortality rates after haploPBSCT were comparable to those reported for allogenic PBSCT. Most critically ill pediatric patients required PICU admission for respiratory complications. Ventilator use independently predicted in-hospital mortality, underscoring the importance of early detection and prevention of respiratory failure following haploPBSCT.

Schlagwörter

Stichwörter der Autor:innen

ICUhaploidentical peripheral blood hematopoietic stem cell transplantationmortalitypediatricsrisk factor

Autor:innen und Institutionen

  • Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Pediatric Hematology-Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Pediatric Critical Care Medicine, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Kim, D. H., Im, H. J., Jhang, W. K., & Kang, S. H. (2026). Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1782412

Vancouver

Kim DH, Im HJ, Jhang WK, Kang SH. Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1782412

BibTeX
@article{Kim2026,
  author = {Kim, Da Hyun and Im, Ho Joon and Jhang, Won Kyoung and Kang, Sung Han},
  title = {Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1782412}
}
Kostenlos starten →